Unknown

Dataset Information

0

Self-adjusting synthetic gene circuit for correcting insulin resistance.


ABSTRACT: By using tools from synthetic biology, sophisticated genetic devices can be assembled to reprogram mammalian cell activities. Here, we demonstrate that a self-adjusting synthetic gene circuit can be designed to sense and reverse the insulin-resistance syndrome in different mouse models. By functionally rewiring the mitogen-activated protein kinase (MAPK) signalling pathway to produce MAPK-mediated activation of the hybrid transcription factor TetR-ELK1, we assembled a synthetic insulin-sensitive transcription-control device that self-sufficiently distinguished between physiological and increased blood insulin levels and correspondingly fine-tuned the reversible expression of therapeutic transgenes from synthetic TetR-ELK1-specific promoters. In acute experimental hyperinsulinemia, the synthetic insulin-sensing designer circuit reversed the insulin-resistance syndrome by coordinating expression of the insulin-sensitizing compound adiponectin. Engineering synthetic gene circuits to sense pathologic markers and coordinate the expression of therapeutic transgenes may provide opportunities for future gene- and cell-based treatments of multifactorial metabolic disorders.

SUBMITTER: Ye H 

PROVIDER: S-EPMC5412959 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Self-adjusting synthetic gene circuit for correcting insulin resistance.

Ye Haifeng H   Xie Mingqi M   Xue Shuai S   Charpin-El Hamri Ghislaine G   Yin Jianli J   Zulewski Henryk H   Fussenegger Martin M  

Nature biomedical engineering 20161219 1


By using tools from synthetic biology, sophisticated genetic devices can be assembled to reprogram mammalian cell activities. Here, we demonstrate that a self-adjusting synthetic gene circuit can be designed to sense and reverse the insulin-resistance syndrome in different mouse models. By functionally rewiring the mitogen-activated protein kinase (MAPK) signalling pathway to produce MAPK-mediated activation of the hybrid transcription factor TetR-ELK1, we assembled a synthetic insulin-sensitive  ...[more]

Similar Datasets

| S-EPMC5752098 | biostudies-literature
| S-EPMC2481315 | biostudies-literature
| S-EPMC5637407 | biostudies-literature
| S-EPMC8655274 | biostudies-literature
| S-EPMC3573884 | biostudies-literature
| S-EPMC3325171 | biostudies-literature
| S-EPMC4381049 | biostudies-literature
| S-EPMC8136830 | biostudies-literature
| S-EPMC6805884 | biostudies-other
| S-EPMC7246135 | biostudies-literature